These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32279670)

  • 41. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.
    Nemat H; Khan R; Ashraf MS; Matta M; Ahmed S; Edwards BT; Hussain R; Lesser M; Pekmezaris R; Dlugacz Y; Wolf-Klein G
    Am J Gastroenterol; 2009 Aug; 104(8):2035-41. PubMed ID: 19367273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection.
    Vasoo S; Stevens J; Portillo L; Barza R; Schejbal D; Wu MM; Chancey C; Singh K
    J Microbiol Immunol Infect; 2014 Feb; 47(1):75-8. PubMed ID: 22921803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections.
    Bettger CC; Giancola SE; Cybulski RJ; Okulicz JF; Barsoumian AE
    BMC Res Notes; 2023 Aug; 16(1):172. PubMed ID: 37580824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients.
    Schwenk HT; Bio LL; Kruger JF; Banaei N
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):44-50. PubMed ID: 30476169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility.
    Murad YM; Perez J; Nokhbeh R; Ybazeta G; Dewar B; Lefebvre S; Diaz-Mitoma F
    Am J Infect Control; 2015 Apr; 43(4):383-6. PubMed ID: 25687359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.
    Morelli MS; Rouster SD; Giannella RA; Sherman KE
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):669-74. PubMed ID: 15290659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.
    Desai M; Knight K; Gray JM; Nguyen V; Boone J; Sorrentino D
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1099-1105. PubMed ID: 32516177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discordant
    Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
    BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitals.
    Zacharioudakis IM; Zervou FN; Phillips MS; Aguero-Rosenfeld ME
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115346. PubMed ID: 33647544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.
    Christensen AB; Barr VO; Martin DW; Anderson MM; Gibson AK; Hoff BM; Sutton SH; Widmaier V; Salim AA; Silkaitis C; Qi C; Zembower TR; Postelnick MJ; Rhodes NJ
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):269-275. PubMed ID: 30786942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.
    Camargo TS; Junior MS; Camargo LFA; Biotto VP; Doi AM; Koga PCM; França CN; Martino MDV
    Arch Microbiol; 2021 May; 203(4):1683-1690. PubMed ID: 33459815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.
    Widmer AF; Frei R; Kuijper EJ; Wilcox MH; Schindler R; Spaniol V; Goldenberger D; Egli A; Tschudin-Sutter S
    Emerg Infect Dis; 2020 Oct; 26(10):2370-2377. PubMed ID: 32946368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.